EOM 1352: Fri 7 June 2024, 11:36

Current Edition

Discovery Park: Wed 13 November 2024, 10:35
ramusmedical
Regional News

CluePoints’ Technology Named as Finalist in 2025 Citeline Awards

RBQM and AI leader was shortlisted for its Time Similarity Test in the ‘Innovative Clinical Trial Solutions’ category King of Prussia, PA – April 15th, 2025: Clue...
Continue Reading →
Regional News

NeOnc Technologies Expands Global Clinical Trial Network with CBCC Global Research to Accelerate Study of Brain Cancer Treatments

NeOnc Technologies Holdings, Inc. (Nasdaq Global Market: NTHI), a clinical-stage medical biotechnology company, today announced a strategic partnership with CBCC Glo...
Continue Reading →
Regional News

EMA Panel Endorses AI for MASH Clinical Trials

An artificial intelligence model developed by PathAI – used to help diagnose metabolic dysfunction associated steatohepatitis (MASH) from liver biopsy samples – has ...
Continue Reading →
Regional News

Clinical Trial Shows Oral Semaglutide Vastly Reduces Heart Attacks, Strokes in People with Type 2 Diabetes

Both the injectable and oral forms of semaglutide, a glucagon-like peptide-1 receptor agonist, have gained recent attention for their effectiveness against weight ga...
Continue Reading →
Regional News

Avalyn Completes Successful Phase 1 Clinical Trials of AP02, its Novel Inhaled Formulation of Nintedanib, Preparing for Phase 2 Development in Idiopathic Pulmonary Fibrosis

Topline data from the single- and multiple-ascending dose studies confirmed safety and favourable tolerability profile of AP02 at all dose levels Full safety, tol...
Continue Reading →
Regional News

Dementia Patients and their Carers to be Asked about Direction of Drug Research

Cambridge researchers are seeking the views of people with lived experience of dementia – patients and their friends and families – on which existing drugs should be...
Continue Reading →
Regional News

AI-Assisted Screening Tool Speeds Trial Eligibility Determination

The AI-assisted screening tool identified eligible candidates faster and with a higher eligibility rate (20.4% vs 12.7%) than manual screening. Compared with manu...
Continue Reading →
Regional News

First Patient Enrolled in Phase 3 Recurrent Prostate Cancer Trial

The first patient has been enrolled in the phase 3 PROSTATE-IQ trial being conducted in men with prostate cancer recurrence following a prostatectomy. The first p...
Continue Reading →
Regional News

Keytruda’s Liver Cancer Approval Secured by New Study

Merck & Co's FDA approval for Keytruda in advanced liver cancer looks secure, after an Asian clinical trial found that the cancer immunotherapy improved survival...
Continue Reading →
Regional News

FDA Approves Clinical Trials for Pig Kidney Transplants in Humans

HealthDay News — The US Food and Drug Administration (FDA) has approved the first-ever clinical trials testing pig kidney transplants in people with kidney fail...
Continue Reading →
Catalyst: Fri 8 November 2024, 14:16
Biosynth: Wed 13 November 2024, 10:18